NYSEAM:IBIO 8 December 2025

Biggest Stock Gainers Today: Biotech Breakouts and IBM–Confluent Deal Lead U.S. Market Movers (December 8, 2025)

U.S. stocks were little changed Monday ahead of the Federal Reserve meeting, with the S&P 500 and Dow down 0.03% and the Nasdaq 100 up 0.07%. Small-cap stocks surged, led by biotech firms on clinical trial results and M&A news. Cemtrex soared 134%, Structure Therapeutics 97%, and Wave Life Sciences 92%. The Russell 2000 rose 0.55% intraday.

8 December 2025

Mergers & Acquisitions·NASDAQ:CETX·NASDAQ:CFLT·NASDAQ:FULC·NASDAQ:GPCR·NASDAQ:WVE·NYSE:IBM·NYSEAM:IBIO·Stock Market

Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).